| CORT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CORT market cap history going back to 3/15/2010:
Also see: CORT Shares Outstanding History and CORT YTD Return |
CORT Market Cap History — Corcept Therapeutics Capitalization Over Time
As of 4/23/2026 Corcept Therapeutics has a market cap of 4.84 billion. Investors often follow the CORT market cap history to compare the size of the company over time.
This page shows CORT market capitalization trends over time, with 67 market cap datapoints presented, dating back to 3/15/2010.
| CORT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CORT Historical Market Cap: +22.96% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CORT Stock Price Chart |
| About Corcept Therapeutics Inc |
| Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. Co. operates through the discovery, development and commercialization of the pharmaceutical products segment. Co. has marketed Korlym (mifepristone) in the U.S. for the treatment of patients suffering from Cushings syndrome. Co.'s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. We show 67 historical shares outstanding datapoints in our CORT shares outstanding history coverage, used to compute CORT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CORT market cap history over the course of time is important for investors interested in comparing CORT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CORT versus a peer is one thing; comparing CORT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CORT can fluctuate over the course of history. With this page we aim to empower investors researching CORT by allowing them to research the CORT market cap history. |
| CORT Current Stock Quote |
Quotes delayed 20 minutes  Free CORT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CORT Share Performance |
| Market Cap Peers |
| Corcept Therapeutics (CORT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
COSM Market Cap History COT Market Cap History COYA Market Cap History CPIX Market Cap History CPRX Market Cap History CRBP Market Cap History CRBU Market Cap History CRDF Market Cap History CRGX Market Cap History CRH Market Cap History More Healthcare companies » |
CORT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
